BJ
Insider
Bruce N. Jacobs
Chief Financial OfficerBruce N. Jacobs (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $8.9M of KYMR (77,109 sh across 8 lots, as filed), executed Jun 30.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$9.9M
shares × price, as filed
Last traded
Jun 30
Filed Jul 2
Median ADV $102.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $14.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
KYMRRecent filings
KYMRSALE
Kymera Therapeutics, Inc.
View filing →
$8.9M77,109 sh across 8 lots
Exec Jun 30
Filed Jul 2 · 6:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $1.0M
11,532 sh across 5 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $4.0M
79,220 sh × $50.00
Exec Sep 17 2025
Filed Sep 17 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $175K
5,754 sh × $30.33
Exec Mar 3 2025
Filed Mar 3 2025 · 5:30 PM ET